VRTX

VRTX Company Financials

$78.8
*  
0.05
  negative  
0.06%
Get VRTX Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VRTX Pre-Market
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$1,527,042 $1,410,626 $143,370 $101,889
Cost of Revenue
$279,885 $80,505 $12,730 $14,202
Gross Profit
$1,247,157 $1,330,121 $130,640 $87,687
Operating Expenses
Research and Development
$806,185 $707,706 $637,416 $550,274
Sales, General and Admin.
$436,796 $400,721 $187,800 $130,192
Non-Recurring Items
$1,844 $107,874 $1,501 $21,233
Other Operating Items
$0 $0 $0 $0
Operating Income
$2,332 $113,820 ($696,077) ($614,012)
Add'l income/expense items
$1,940 ($14,923) ($39,274) ($14,974)
Earnings Before Interest and Tax
$4,272 $98,897 ($735,351) ($628,986)
Interest Expense
$16,653 $38,452 $19,275 $13,192
Earnings Before Tax
($12,381) $60,445 ($754,626) ($642,178)
Income Tax
$38,754 $19,266 $0 $0
Minority Interest
($55,897) ($11,605) $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($107,032) $29,574 ($754,626) ($642,178)
Net Income
($107,032) $29,574 ($754,626) ($642,178)
Net Income Applicable to Common Shareholders
($107,032) $29,574 ($754,626) ($642,178)

See also: Company Financials data entry page